Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

513.12
-7.8800-1.51%
Post-market: 513.310.1900+0.04%19:30 EDT
Volume:415.57K
Turnover:215.18M
Market Cap:22.01B
PE:18.36
High:528.02
Open:523.23
Low:512.29
Close:521.00
52wk High:609.35
52wk Low:302.19
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.96
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.44
PE(LYR):18.42

Loading ...

United Therapeutics Q1 FY26 net income drops 15% to $274.9 million; revenue slips 2% to $781.5 million

Reuters
·
May 06

BRIEF-United Therapeutics Q1 Revenue USD 781.5 Million Vs. IBES Estimate USD 796.9 Million

Reuters
·
May 06

United Therapeutics Corporation Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 06

United Therapeutics Q1 EPS USD 5.82

THOMSON REUTERS
·
May 06

United Therapeutics CFO James Edgemond disposes 10,000 shares for $5.77 million

Reuters
·
May 06

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.41 million

Reuters
·
May 05

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.41 million

Reuters
·
May 02

United Therapeutics CFO James Edgemond disposes of shares worth $5.01 million

Reuters
·
May 02

United Therapeutics CEO Martine Rothblatt disposes of shares worth $3.37 million

Reuters
·
May 01

United Therapeutics announces retirement of Professor Dwek from board

TIPRANKS
·
Apr 29

Earning Preview: United Therapeutics this quarter’s revenue is expected to increase by 9.51%, and institutional views are bullish

Earnings Agent
·
Apr 29

United Therapeutics director Raymond Dwek retires from board, term ends June 26, 2026

Reuters
·
Apr 29

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.b.e., F.r.s., From Its Board of Directors

THOMSON REUTERS
·
Apr 29

United Therapeutics CEO Martine Rothblatt disposes of 10,500 shares worth $5.99 million

Reuters
·
Apr 29

United Therapeutics CFO James Edgemond disposes of shares worth $5.32 million

Reuters
·
Apr 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: United Therapeutics (UTHR), Insmed (INSM) and MannKind (MNKD)

TIPRANKS
·
Apr 28

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.37 million

Reuters
·
Apr 28

United Therapeutics CFO James Edgemond sells 10,000 shares for $5.72 million

Reuters
·
Apr 25

United Therapeutics director Christopher Patusky sells 2,910 shares for $1.66 million

Reuters
·
Apr 25

United Therapeutics Corp : RBC Raises Target Price to $707 From $700

THOMSON REUTERS
·
Apr 24